Georgia 2023-2024 Regular Session

Georgia House Bill HB181

Introduced
1/31/23  
Report Pass
3/2/23  
Introduced
1/31/23  
Engrossed
3/6/23  
Report Pass
3/2/23  
Refer
3/7/23  
Engrossed
3/6/23  
Report Pass
3/21/23  
Refer
3/7/23  
Report Pass
2/8/24  
Report Pass
3/21/23  
Enrolled
4/3/24  
Report Pass
2/8/24  
Chaptered
5/2/24  
Enrolled
4/3/24  
Chaptered
5/2/24  

Caption

Controlled Substances; mitragynine and hydroxymitragynine are Schedule I; provide

Impact

By regulating the sale of kratom, HB 181 aims to reduce the risks associated with its use, especially among younger populations. The bill introduces penalties for violations of its provisions, categorizing many offenses as misdemeanors with increasing punishments for repeated offenses. This legislation is part of a broader attempt to manage the influence and potential hazards of kratom on public health and safety, thereby impacting how the substance is legally handled within the state.

Summary

House Bill 181 seeks to regulate the sale and distribution of kratom, a substance derived from the Mitragyna speciosa plant. The bill establishes a legal framework that includes an age restriction prohibiting the sale or transfer of kratom to individuals under 21 years of age. It mandates specific packaging requirements, labeling, and the maintenance of a registered agent by manufacturers. Furthermore, it prohibits the sale of kratom through vaporizing mechanisms, aimed at ensuring consumer safety and controlling the consumption methods of this product.

Sentiment

The sentiment surrounding HB 181 appears to be largely supportive among those advocating for consumer protection and public health. Proponents argue that the regulations are necessary to prevent access to kratom by minors and to ensure the quality and safety of products available in the market. On the other hand, some critics express concerns about the repercussions this might have on consumers who use kratom responsibly, particularly those who may rely on it for relief from various ailments.

Contention

Notable points of contention include the age limit introduced and the specific prohibitions against vaporization of kratom. While some legislators argue that this is essential for safeguarding youth, others believe that such restrictions could encroach on personal freedoms and rights of adult users. The bill’s approach to kratom as a potential controlled substance has started debates on how substances should be regulated and the balance between public health and individual rights.

Companion Bills

No companion bills found.

Previously Filed As

GA HB968

Controlled substances; mitragynine and hydroxymitragynine (7-OH) are Schedule I; provide

GA HB1101

The scheduling of mitragynine as a schedule I controlled substance.

GA SB534

To Establish The Arkansas Kratom Consumer Protection Act; And To Remove Mitragynine And 7-hydroxymitragynine, Also Known As Kratom, From The Controlled Substances List In Arkansas.

GA SB899

Further providing for schedules of controlled substances.

GA SB1605

Makes 7-hydroxymitragynine in certain amounts a Schedule I controlled substance

GA H0864

Amends existing law to provide that certain substances involving mitragynine shall be Schedule I controlled substances.

GA HB1329

Controlled substances; Schedule I; provide certain provisions

GA HB473

Controlled substances; Schedule I; provide certain provisions

GA A1636

Classifies 7 Hydroxymitragynine as Schedule I drug and bans sale of products containing substance.

GA HB1101

A BILL for an Act to amend and reenact subsection 3 of section 19-03.1-05 of the North Dakota Century Code, relating to the scheduling of mitragynine as a schedule I controlled substance.

Similar Bills

No similar bills found.